GC3/c1 human colon adenocarcinoma cells were treated with the mutagen ethyl methanesulfonate, and three clones deficient in thymidylate synthase (5,10-methylenetetrahydrofolate:dUMP C-methyltransferase, EC 2.1.1. 45) activity were selected and characterized. Growth in medium deficient in thymidine caused cell death in two clones (TS-cl and TS-c3), whereas one clone (TS-c2) showed limited growth.
Thymidylate synthase (5,10-methylenetetrahydrofolate: dUMP C-methyltransferase, EC 2.1.1.45; dTMP synthase) catalyzes the conversion of dUMP to dTMP and in mammalian cells functions as the only de novo source of dTMP. This enzyme has thus been of considerable interest as a target for cancer chemotherapeutic agents (1) (2) (3) . dTMP synthase is considered to be the primary site of action for 5-fluorouracil (FUra), 5-fluoro-2'-deoxyuridine (FdUrd) , and the folate analogues 5,8-dideazaisofolic acid and N10-propargyl-5,8-dideazafolic acid (3) (4) (5) . Further, polyglutamyl derivatives of methotrexate are inhibitors of this enzyme (6) . Despite the availability of potent inhibitors of dTMP synthase, most human cancers are intrinsically resistant to agents acting at this locus. For FUra many mechanisms for intrinsic and acquired resistance have been proposed (reviewed in ref. 3) . In studies using human colon adenocarcinomas maintained in mice as xenografts, intrinsic resistance to FUra appeared to be a consequence of relatively transient inhibition of dTMP synthase (7) . This appeared to be due to low levels of 5,10-methylenetetrahydrofolate (CH2-H4PteGlu), or its polyglutamyl derivatives, required to stabilize the covalent ternary complex of the FUra metabolite FdUMP, enzyme, and CH2-H4PteGlu (8) . An alternative mechanism of intrinsic resistance, namely salvage of thymidine (dThd), appeared of little significance, as cloned lines deficient in dThd kinase (9) , growing as xenografts, were no more sensitive to FUra than the parental line. These data also indicated that colon adenocarcinoma cells, obligated to dTMP synthesis de novo, were tumorigenic in mice. However, the significance of dThd salvage in vivo under conditions of complete and prolonged inhibition of dTMP synthase remained unanswered. In experiments reported here we selected and characterized three clones of GC3/cl, a human colon adenocarcinoma (9) , each deficient in dTMP synthase (TS-). Each TS-clone retained tumorigenic potential in athymic mice and retained histologic characteristics of the parental cloned line.
MATERIALS AND METHODS
Materials. Sephadex G-25 columns (PD10) were obtained from Pharmacia. [5-3H] Cell Culture. The GC3/M cell line, derived from a human colon adenocarcinoma grown initially as a xenograft in mice, has been described (9) . From this line, clones were obtained by conventional methods (10) . GC3/cl was maintained in RPMI 1640 (Hazleton Research Products, Reston, VA) containing 10% fetal bovine serum (FBS; Hyclone) without added antibiotics.
Selection of TS-Cells. Clones of GC3/cl deficient in dTMP synthase were selected (on passage 56 for TS-c2 and TS-c3 and on passage 57 for TS-c1) by a procedure similar to that of Li and Chu (11) . Cells (2 x 106 per T75 flask) were exposed for 18 hr to ethyl methanesulfonate (600 ,g/ml), washed, and refed with RPMI 1640 containing 10% FBS and 10 ,uM dThd. Cells were refed after 3 days with supplemented medium. After an additional 2 days, cells from 10 culture flasks were pooled and plated at 7 x 105 cells per 100-mm dish. Cells were grown in selection medium (RPMI 1640 containing 5% dialyzed FBS, 1.0 uM aminopterin, 10 ,tM dThd, 0.1 .tM folinic acid, and 100 units of penicillin and 100 ,g of streptomycin per ml) and subsequently were maintained in this medium for 19 days, at which time 17 colonies were isolated by using cloning cylinders. Selection frequency was 8.5 x 10-7. Cells from individual colonies were trypsinized and replated in one well of a 24-well plate. Cells were maintained in selection medium for a further 8 days, at which time cells from 9 of the original colonies were viable. Four of (13); cell number was determined by counting nuclei (Coulter ZM) after cell lysis, according to the procedure of Butler (14) . FdUMP Binding Assay. Cell supernatants were prepared as above, and [6-3H]FdUMP (87.7 ,uM) was substituted for [5-3H] dUMP. Formation of covalent ternary complex was assayed by adsorption of unbound FdUMP to charcoalalbumin-dextran (7).
Incorporation of [6-3H] dUrd into DNA. Cells were plated (5 x 106 per dish) in 35-mm dishes (Falcon 3001) and allowed to attach for 14-16 hr. Medium was aspirated and replaced with 1 ml of RPMI 1640 containing 10% FBS and 2 ,Ci of [6-3H] dUrd. Cells were incubated at 37°C for up to 30 min. At the appropriate time, radiolabeled medium was aspirated and the m9nolayer was washed twice with ice-cold phosphatebuffered saline. Cells were solubilized in 1 M KOH (37°C, 60 min), and DNA was extracted by a modified SchmidtThannhauser procedure (15) . Radiolabel incorporated into alkali-stable, acid-precipitable material was determined after hydrolysis in 1 M perchloric acid (65°C, 1 hr). In some experiments [5-3H]dUrd was substituted for [6-3H] 
For autoradiographic studies, 105 cells were plated per plastic microscope slide (9) and, after 24 hr, exposed to [6-3H] dUrd (1 ,uCi/ml) for 1 hr. Cells were fixed in 95% ethanol and autoradiographs were produced. For analysis of [6-3H] dUrd labeling index, at least 5000 cells were scored.
Growth of Heterografts. Cells selected for dTMP synthase deficiency were resuspended at 108 per ml and inoculated subcutaneously into both flanks of three BALB/c athymic nude mice (The Jackson Laboratory). Mice were housed in filter-top cages in a humidity-and temperature-controlled room. Upon reaching a diameter >1.5 cm tumors were excised, and fragments were transplanted subcutaneously in both dorsal flanks of female CBA/CaJ mice that had been immune-deprived by thymectomy at age 4 weeks, followed in 3 weeks by 925-cGy whole-body irradiation and rescue with 5 x 106 nucleated marrow cells (16) .
Hybridization Studies. RNA was extracted from 108 cells by a modified method of Feramisco et al. (17) . Poly(A)+ RNA was purified by chromatography over oligo(dT)-cellulose and quantitated by determining optical density (OD260/OD280 > 1.8; 1 OD260 unit = 40 jig of RNA per ml). For Northern blot analysis, poly(A)+ RNA was separated according to size by electrophoresis in 1% agarose containing 6 M formaldehyde and transferred to nitrocellulose by conventional techniques. For dot blot quantitation, poly(A)+ RNA denatured in 1OX SSC (lx is 0.15 M NaCl/0.015 M sodium citrate, pH 7.0) containing 4.68 M formaldehyde was applied to nitrocellulose. Filters were incubated for at least 2 hr at 420C in prehybridization buffer containing 50% formamide, Sx SSC, lx Denhardt's solution (0.02% Ficoll/0.02% polyvinylpyrrolidone/0.02% bovine serum albumin), 0.1% SDS, 20 mM sodium phosphate (pH 6.5), and 250 ,ug of denatured salmon sperm DNA per ml. Hybridization was allowed to proceed for at least 15 hr at 420C in a minimal amount (50 ,ul/cm2) of the same buffer with added 32P-labeled probe (106 cpm/ml). Filters were washed four times for 5 min at room temperature in 2x SSC/0.1% SDS and four times for 15 min at 50'C in 0.1x SSC/0.1% SDS before they were processed for autoradiography.
pcHTS 6 days was determined for TS-c1 at passage 63 (TS-c1p63; passage 6 after selection), TS-c2p63 (passage 7 after selection), and TS-c3p62 (passage 6 after selection) in the presence of various dThd concentrations. At optimal dThd, growth rates for TS-clones were 5%, 18%, and 16% that of GC3/c1 grown in the absence of dThd. Each result is the mean of three determinations. Fig. 3 . For GC3/cl the ternary complex migrated at 36 kDa; a similar band, but with reduced intensity, was observed for TS-c2 and TS-c3. No ternary complex was observed in TS-c1 extracts. Thus each assay gave qualitatively similar data for these clones.
To determine whether low levels of dTMP synthase activity were a consequence of altered transcription, Northern blots of mRNA were probed with pcHTS-1 radiolabeled by nick-translation. mRNA complementary to pcHTS-1 was detected in each of the TS-clones, although the level was lower in TS-c3 (Fig. 4) . In each case mRNA migrated with were bound to nitrocellulose and hybridized to 32P-labeled pcHTS-1.
Results demonstrate very low signal in TS-c3 extracts. Table 3 and indicate that TS-c1 subclones are generally stable, whereas TS-c3/c2 had reverted, was able to grow in dThd-free medium, and had 15% of control dTMP synthase activity. Growth as Heterografts. Previous work demonstrated that mutants of GC3/cl deficient in dThd kinase were tumorigenic in immune-deprived mice (ref. 9 and unpublished data). It was thus of interest to determine whether clones deficient in dTMP synthase (dThd auxotrophs) were also capable of forming tumors in vivo. Approximately 107 cells from each primary TS-clone (passage 64 or 65) were inoculated bilaterally into the subcutaneous space of BALB/c athymic nude mice. Each line was tumorigenic, producing tumors in two of three mice, and the tumors maintained the poorly differentiated histological characteristics of the parental clone. Subsequently, each line was transplanted into immune-deprived CBA/CaJ mice after growth in nude mice for 122 and 173 days, respectively. Progressively growing TS-cl and TS-c3 second-passage tumors were examined 250 and 294 days after initial inoculation into mice. Immune-deprived mice received [6-3H]dUrd (1 uCi/g of body weight), tumors were excised after 1 hr, and autoradiographs were produced.
The labeling index for TS-cl and TS-c3 was 42% and 44%, respectively, of that for GC3/cl.
DISCUSSION
Although TS-mutants of rodent cells have been reported (11, 20) and extensively characterized (21) , no mutants of human cells have been reported. We were specifically interested in deriving TS-mutants from a human colon adenocarcinoma as this locus is a major focus for therapy of these cancers and the consequences of thymidine restriction remain to be fully characterized in human cells. Three clones were selected, two of which were auxotrophic for dThd. Assay for dTMP synthase activity using [5-3H] dUMP revealed low or undetectable activity in TS-c3 and TS-c1, respectively. Growth of TS-cl and TS-c3 was optimal at >5 ,uM dThd, whereas its parental clone GC3/cl grew optimally without dThd. However, in comparison to the parental clone, apparent growth rates were 5%, 18%, and 16% for TS-cl, TS-c2, and TS-c3, respectively. The low growth rate in TS-c1 is a consequence Table 3 . Characterization of secondary TS-clones of an increased population doubling time of 52 hr compared to 24 hr for GC3/cl. Incorporation of [6-3H] dUrd into DNA paralleled enzyme activity in TS-c1 and TS-c3 being 1.1% and 9.7% of the rate for the parental clone. To determine whether TS-c1 could incorporate dUTP into DNA, similar experiments using [5-3H]dUrd were performed. There was no incorporation of radiolabel into DNA. FdUMP binding assays gave results qualitatively similar to those of the catalytic assay, with no detectable binding in TS-c1. Further, in TS-c1, no ternary complex could be detected after SDS/PAGE.
Both TS-c1 and TS-c2 appeared to have normal levels of mRNA detected by hybridization with a human cDNA dTMP synthase probe. Analysis revealed a major band at =1.6 kilobases, with a minor band at 3.8 kilobases, similar to that reported for TIG-1 normal human fibroblasts (22) . For TS-c3 the level of dTMP synthase mRNA (relative to the signal for an actin probe) was lower, =6% of the ratio determined in GC3/cl cells. Whether this is a consequence of reduced transcription or of altered stability of this mRNA remains to be determined.
We further characterized TS-c3 with respect to its sensitivity to FUra, FdUrd, and MTX (Table 2) . For both fluoropyrimidines, dThd reversed growth inhibition in the parent clone (GC3/cl), indicating that dTMP synthase was the primary target for cytotoxicity. In the presence of dThd to allow growth (6.3 ,uM), the IC50 values for FUra and FdUrd were increased 32-fold and 750-fold in TS-c3 relative to GC3/cl. These results are in contrast to those of Akazawa et al. (23) , who reported increasing cytotoxicity of FUra in the presence of dThd and no difference in sensitivity between mouse mammary tumor line FM3A and its TS-derivative. The TS-c3 line was also highly resistant to MTX (>100,000-fold) as would be anticipated in a cell line in which dTMP synthase activity was negligible, since the loss of reduced folates through the dTMP synthase reaction under conditions of dihydrofolate reductase inhibition would be reduced. Data also suggested that in this line, MTX or its polyglutamyl metabolites per se did not exert growth inhibition due to secondary or tertiary sites of action [e.g., phosphoribosylaminoimidazolecarboxamide formyltransferase (24) Data indicated that clones TS-c1 and TS-c3 were deficient in dTMP synthase. Clone TS-c2 appeared to have some enzyme activity and by passage 67 was capable of limited growth in the absence of dThd, whereas TS-c1 and TS-c3 were more stable. To examine stability of TS-c1 and TS-c3, secondary cloning was undertaken, and individual subclones were expanded to >1010 cells over a period of 10 weeks. At this time only one clone, TS-c3/c2, demonstrated growth in dThd-free medium; however, TS-c3/c4 demonstrated few (0.35%) heavily radiolabeled cells by autoradiography after exposure to [6-3H] dUrd. In contrast, clones derived from TS-c1 appeared relatively stable, and radiolabeled cells were detected in only one clone (TS-c1/c3), at very low frequency. The growth rate of both primary and secondary TS-clones suggests that salvage of dThd was inadequate for optimal growth in these cells.
It was thus of interest to determine whether these TSclones were tumorigenic in mice, where plasma concentrations of dThd have been reported to be <1 ttM (25, 26) .
Tumor cells were inoculated into BALB/c athymic mice, and each clone produced tumors in two of three mice. Thus, at a time when primary clones were dThd auxotrophs (passages 63 and 64), they retained tumorigenic potential. However, analysis of second-passage transplants demonstrated incorporation of [6-3H] dUrd into -5% of tumor cells (40% of that in GC3/cl). Thus, within 250 days after initial inoculation, TS' cells comprised at least 40% of the tumor population. Whether tumor growth was initiated by inoculating very few TS' cells remains to be examined in detail, by using secondary TS-clones. However, if the differential growth rate in vitro between TS-and TS' clones of GC3 were maintained in mice, the overgrowth of TS-cells by revertants would be rapid. That the labeling index was only 40% of the control level suggests that at this time TS-cells are present in the tumor population. Studies to examine early stages of tumor growth are necessary to resolve this. However, other data confirm that relatively low concentrations of dThd may protect GC3/c1 cells when dTMP synthase is inhibited. At a concentration of FUra that reduced clonogenicity to <3% of control, addition of 0.1 or 1.0 ,uM dThd increased colony formation to 25% and 66%, respectively (S. Radparvar, P.J.H., and J.A.H., unpublished data). Hence, dThd concentrations found in humans and mice may provide adequate protection for cells in which dTMP synthase has been inhibited, and may support growth of TS-mutants.
The current data indicate that in situ salvage of dThd may limit cytotoxicity due to complete and prolonged inhibition of dTMP synthase induced by chemotherapeutic agents. These mutants will be of value in determining the consequences of dTTP depletion and events that may cause death (27) of human colon cancer cells.
Note Added in Proof. TS-c1/c1p69 cells injected into athymic mice formed tumors within 100 days of inoculation.
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